Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Multivariate analysis: breast and bowel screening uptakes by deprivation

From: Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics

Cancer screening Programme/Round Deprivation Number Uptake (%) Adjusted OR (95% CI)
  1 & 2 (Least) 15535 80.86 1 (-)
  3 17387 78.35 0.87** (0.82, 0.91)
Breast screening 4 15894 72.54 0.64** (0.61, 0.68)
Round 1: 1989–92 5 5224 68.09 0.53** (0.49, 0.56)
  6 & 7 (Most) 3193 61.13 0.41** (0.38, 0.45)
  1 & 2 (Least) 17374 80.99 1 (-)
  3 18390 79.28 0.91** (0.86, 0.95)
Breast screening 4 15847 75.12 0.73** (0.69, 0.77)
Round 2: 1992–95 5 5051 68.62 0.53** (0.50, 0.57)
  6 & 7 (Most) 3020 61.39 0.42** (0.38, 0.45)
  1 (Least) 16903 82.18 1 (-)
  2 17002 81.27 0.95+ (0.90, 1.00)
Breast screening 3 17228 80.50 0.91** (0.86, 0.96)
Round 5: 2001–04 4 17117 76.37 0.72** (0.68, 0.76)
  5 (Most) 17351 67.60 0.48** (0.45, 0.50)
  1 (Least) 16107 67.78 1 (-)
  2 23420 66.95 0.96* (0.92, 1.00)
Bowel screening 3 25225 65.03 0.88** (0.84, 0.91)
Round 1: 2000–02 4 28301 58.68 0.68** (0.66, 0.71)
  5 (Most) 29855 46.34 0.44** (0.42, 0.45)
  1 (Least) 14444 63.18 1 (-)
  2 21831 61.45 0.92** (0.88, 0.96)
Bowel screening 3 24090 59.55 0.84** (0.81, 0.88)
Round 2: 2003–05 4 26852 52.80 0.66** (0.63, 0.68)
  5 (Most) 28823 40.98 0.43** (0.41, 0.45)
  1. + Non-significant p > 0.05
  2. * Significant at p < 0.05
  3. ** Significant at p < 0.001